logo

For the Inventor, By the Inventor

Leichlingen, Germany

Ulf Brüggemeier

This inventor holds 14 USPTO granted patents and 13 published patent applications and 7 EPO patents. Top assignees: Bayer Healthcare Aktiengesellschaft, Bayer Pharma Aktiengesellschaft, Bayer Schering Pharma Ag. Active years: 1998-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ulf Brüggemeier. Retrieved from https://idiyas.com/inventor/ulf-bruggemeier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 14.3

 

Average Co-Inventor Count = 5.2

ph-index = 5

Forward Citations = 58(Granted Patents)


Company Filing History:

goldMedal3 out of 77 
 
Bayer Healthcare Aktiengesellschaft
 patents
silverMedal3 out of 387 
 
Bayer Pharma Aktiengesellschaft
 patents
bronzeMedal3 out of 192 
 
Bayer Schering Pharma Ag
 patents
4. 2 out of 12,269 
 
Bayer Aktiengesellschaft
 patents
5. 2 out of 721 
 
Bayer Intellectual Property Gmbh
 patents
6. 1 out of 757 
 
Siemens Healthcare Diagnostics Gmbh
 patents

Years Active: 1998-2014

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 8859601 - Substituted benzyl and phenylsulfonyl triazolones, and use thereof (2014-10-14),
2. 8796324 - Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof (2014-08-05),
3. 8343745 - Acylglycerol acyltransferase-like protein MGAT-X1 and uses thereof (2013-01-01),
4. 8252525 - Diagnostics and therapeutics for diseases associated with G-protein coupled receptor AdipoR1(AdipoR1) (2012-08-28),
5. 8202895 - Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof (2012-06-19),
6. 8088584 - LTBP2 as a biomarker and diagnostic target (2012-01-03),
7. 8084481 - Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptors (2011-12-27),
8. 7803593 - Acylglycerol acyltransferase-like protein MGAT-X1 and uses thereof (2010-09-28),
9. 7776922 - Substituted [(phenylethanoyl)amino]benzamides (2010-08-17),
10. 7491550 - Diagnostics and therapeutics for diseases associated with Neuromedin U2 receptor (NMU2) (2009-02-17),
11. 7465548 - Methods of screening for potential therapeutics for diseases associated with G-protein coupled receptor HM74a (2008-12-16),
12. 7338781 - Organic anion transporting (oat)-like protein UST3-LIKE1 and uses thereof (2008-03-04),
13. 7220824 - Integrin-mediated drug targeting (2007-05-22),
14. 5723031 - Method for the analytical separation of viruses (1998-03-03),

Title: Inventor Ulf Brüggemeier

Introduction: Ulf Brüggemeier is a renowned inventor hailing from Leichlingen, Germany, known for his groundbreaking contributions to various fields.

Latest Patents: Ulf Brüggemeier holds several patents in the areas of renewable energy technologies, sustainable materials, and innovative manufacturing processes.

Career Highlights: With a career spanning over two decades, Ulf Brüggemeier has worked with leading research institutions and companies to develop cutting-edge solutions that have had a significant impact on the industry.

Collaborations: Throughout his career, Ulf Brüggemeier has collaborated with top scientists, engineers, and inventors from around the world, fostering a culture of innovation and excellence.

Conclusion: Ulf Brüggemeier's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…